Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
360
Trial Sponsor
Trial Collaborator
Clinical Trial Start Date
2024
0Primary Completion Date
2027
0Study Completion Date
2029
0Clinical Trial Study Type
Observational0
Observational Clinical Trial Type
Case-Only0
Observational Study Perspective
Cross-Sectional0
Participating Facility
Official Name
Investigating the Role of the Gut Microbiome in Huntington's Disease0
Last Updated
June 7, 2024
0Study summary
The purpose of this study is to find out if there is a connection between the naturally occurring bacteria in our bodies and the progression of Huntington disease. The investigators are trying to determine if patients who are diagnosed with adult-onset HD and who exhibit a rapid rate of disease progression have unique populations of bacteria in their gut as compared to patients with slower progression.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
